SAN FRANCISCO, Sept. 14, 2026 /PRNewswire/ -- investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company reported Q3 2026 financial results that included revelations of its U.S. channel inventory destocking along with other negative surprises.
SAN FRANCISCO, Sept. 12, 2026 (GLOBE NEWSWIRE) -- On September 10, 2026, investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company reported Q3 2026 financial results that included revelations of its U.S. channel inventory destocking along with other negative surprises.
Cooper Cos. stock has fallen about 25% since Barron's recommended it, but a low valuation, aggressive share buybacks, and takeover potential bolster the bull case.
Shares of Cooper Cos. are pacing the S&P 500's decliners Thursday after the maker of medical devices reported mixed results, issued soft guidance and wrapped up a strategic review without plans to seek a deal.
The contact lens maker just sprung a surprise no one saw coming.
Taiwan Semi posts record August revenue, but that fails to spark a rally in AI stocks.
SAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026.